Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.82 -0.09 (-10.28%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alaunos Therapeutics (TCRT) Non Operating Interest Expenses (2021 - 2023)

Updated

Alaunos Therapeutics' Non Operating Interest Expenses came in at $1.92 million for FY2023, down 40.0% from $3.2 million in FY2022.

Analysis

Alaunos Therapeutics (TCRT) Non Operating Interest Expenses (2021 - 2023) Analysis & Trends

  • Per Business Quant, earlier years put Non Operating Interest Expenses at $3.2 million in FY2022 (+166.7%) and $1.2 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 281.00 Mn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -462.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -435.00 Mn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 247.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Alaunos Therapeutics 2.24 Mn -1.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.07 Mn
Mar 31, 2023 900,000.00
Dec 31, 2022 900,000.00
Sep 30, 2022 841,000.00
Jun 30, 2022 740,000.00
Mar 31, 2022 700,000.00
Dec 31, 2021 756,000.00
Sep 30, 2021 444,000.00
API Access

Alaunos Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=TCRT&period=max&api_key=YOUR_API_KEY